Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation

Autor: Emilie Venereau, François Bernard, Laurence Preisser, Gérard Guillet, Emmanuel Guignouard, Elisa Ravon, Jérôme Pène, Caroline Diveu, Martine Garcia, Franck Morel, Jean-Claude Lecron, G. Dagregorio, Sylvie Chevalier, Josy Froger, Katia Boniface, Hugues Gascan, Jean-Pierre Molès, Nathalie Pedretti, Hans Yssel
Přispěvatelé: Laboratoire Inflammation, Tissus épithéliaux et Cytokines (LITEC), Université de Poitiers, Cytokines : structure, signalisation et prolifération tumorale, Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM), BIOalternatives (BIOalternatives SAS), entreprise privé, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Immunopathologie de l'Inflammation, Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM), Morel, Franck
Jazyk: angličtina
Rok vydání: 2007
Předmět:
S100A7
Keratinocytes
STAT3 Transcription Factor
medicine.medical_treatment
T-Lymphocytes
Immunology
Inflammation
Dermatitis
Oncostatin M
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
Proinflammatory cytokine
03 medical and health sciences
0302 clinical medicine
Cell Movement
medicine
Immunology and Allergy
Humans
Keratinocyte migration
[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biochemistry [q-bio.BM]

[SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunity
[SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biochemistry [q-bio.BM]

Cells
Cultured

ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Oligonucleotide Array Sequence Analysis
Skin
Mitogen-Activated Protein Kinase Kinases
0303 health sciences
biology
fungi
[SDV.MHEP.DERM] Life Sciences [q-bio]/Human health and pathology/Dermatology
Glycoprotein 130
Immunity
Innate

medicine.anatomical_structure
Cytokine
Gene Expression Regulation
[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology
030220 oncology & carcinogenesis
[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology
biology.protein
medicine.symptom
Keratinocyte
Receptors
Oncostatin M
Type II

[SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology
Zdroj: Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2007, 178 (7), pp.4615-4622. ⟨10.4049/jimmunol.178.7.4615⟩
Scopus-Elsevier
ISSN: 0022-1767
1550-6606
DOI: 10.4049/jimmunol.178.7.4615⟩
Popis: Cutaneous inflammatory diseases such as psoriasis vulgaris and atopic dermatitis are associated with altered keratinocyte function, as well as with a particular cytokine production profile of skin-infiltrating T lymphocytes. In this study we show that normal human epidermal keratinocytes express a functional type II oncostatin-M (OSM) receptor (OSMR) consisting of the gp130 and OSMRβ components, but not the type I OSMR. The type II OSMR is expressed in skin lesions from both psoriatic patients and those with atopic dermatitis. Its ligand, OSM, induces via the recruitment of the STAT3 and MAP kinase pathways a gene expression profile in primary keratinocytes and in a reconstituted epidermis that is characteristic of proinflammatory and innate immune responses. Moreover, OSM is a potent stimulator of keratinocyte migration in vitro and increases the thickness of a reconstituted epidermis. OSM transcripts are enhanced in both psoriatic and atopic dermatitic skin as compared with healthy skin and mirror the enhanced production of OSM by T cells isolated from diseased lesions. Results from a microarray analysis comparing the gene-modulating effects of OSM with those of 33 different cytokines indicate that OSM is a potent keratinocyte activator similar to TNF-α, IL-1, IL-17, and IL-22 and that it acts in synergy with the latter cytokines in the induction of S100A7 and β-defensin 2 expression, characteristic of psoriatic skin. Taken together, these results demonstrate that OSM and its receptor play an important role in cutaneous inflammatory responses in general and that the specific effects of OSM are associated with distinct inflammatory diseases depending on the cytokine environment.
Databáze: OpenAIRE